Publications 2018

1. Ignacio BJ, Albin TJ, Esser-Kahn AP, Verdoes M. Toll-like Receptor Agonist Conjugation: A Chemical Perspective. Bioconjug Chem, 2018. 29(3): 587-603.

2. Weiden J, Tel J, Figdor CG. Synthetic immune niches for cancer immunotherapy. Nat Rev Immunol, 2018. 18(3): 212-9.

3. Thoemmes F, Rosseel Y, Textor J. Local fit evaluation of structural equation models using graphical criteria. Psychol Methods, 2018. 23(1): 27-41.

4. Baron F, Stevens-Kroef M, Kicinski M, Meloni G, Muus P, Marie JP, Halkes CJM, Thomas X, Vrhovac R, Specchia G, Lefrere F, Sr., Sica S, Mancini M, Venditti A, Hagemeijer A, Becker H, Jansen JH, Amadori S, de Witte T, Willemze R, Suciu S. Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials. Ann Hematol, 2018.

5. Textor J, Fahnrich A, Meinhardt M, Tune C, Klein S, Pagel R, Konig P, Kalies K, Westermann J. Deep Sequencing Reveals Transient Segregation of T Cell Repertoires in Splenic T Cell Zones during an Immune Response. J Immunol, 2018.

6. Swider E, Koshkina O, Tel J, Cruz LJ, de Vries IJM, Srinivas M. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications. Acta Biomater, 2018. 73: 38-51.

7. Rops A, Jansen E, van der Schaaf A, Pieterse E, Rother N, Hofstra J, Dijkman H, van de Logt AE, Wetzels J, van der Vlag J, van Spriel AB. Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice. Kidney Int, 2018. 93(6): 1356-66.

8. Stauder R, Yu G, Koinig KA, Bagguley T, Fenaux P, Symeonidis A, Sanz G, Cermak J, Mittelman M, Hellstrom-Lindberg E, Langemeijer S, Holm MS, Madry K, Malcovati L, Tatic A, Germing U, Savic A, van Marrewijk C, Guerci-Bresler A, Luno E, Droste J, Efficace F, Smith A, Bowen D, de Witte T. Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study. Leukemia, 2018. 32(6): 1380-92.

9. Le Gall CM, Weiden J, Eggermont LJ, Figdor CG. Dendritic cells in cancer immunotherapy. Nat Mater, 2018. 17(6): 474-5.

10. Gorris MAJ, Halilovic A, Rabold K, van Duffelen A, Wickramasinghe IN, Verweij D, Wortel IMN, Textor JC, de Vries IJM, Figdor CG. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment. J Immunol, 2018. 200(1): 347-54.

11. Arnold KF, Ellison G, Gadd SC, Textor J, Tennant P, Heppenstall A, Gilthorpe MS. Adjustment for time-invariant and time-varying confounders in 'unexplained residuals' models for longitudinal data within a causal framework and associated challenges. Stat Methods Med Res, 2018. 962280218756158.

12. de Swart L, Reiniers C, Bagguley T, van Marrewijk C, Bowen D, Hellstrom-Lindberg E, Tatic A, Symeonidis A, Huls G, Cermak J, van de Loosdrecht AA, Garelius H, Culligan D, Macheta M, Spanoudakis M, Panagiotidis P, Krejci M, Blijlevens N, Langemeijer S, Droste J, Swinkels DW, Smith A, de Witte T, Committee ES. Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. Haematologica, 2018. 103(1): 69-79.

13. Schmid C, de Wreede LC, van Biezen A, Finke J, Ehninger G, Ganser A, Volin L, Niederwieser D, Beelen D, Alessandrino P, Kanz L, Schleuning M, Passweg J, Veelken H, Maertens J, Cornelissen JJ, Blaise D, Gramatzki M, Milpied N, Yakoub-Agha I, Mufti G, Rovira M, Arnold R, de Witte T, Robin M, Kroger N. Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation. Haematologica, 2018. 103(2): 237-45.

14. Qiu L, Valente M, Dolen Y, Jager E, Beest MT, Zheng L, Figdor CG, Verdoes M. Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8(+) T Cell Activation. Small, 2018. 14(15): e1703539.

15. de Swart L, Smith A, Haase D, Fenaux P, Symeonidis A, Cermak J, Sanz G, Stauder R, Mittelman M, Hellstrom-Lindberg E, Malcovati L, Langemeijer S, Skov-Holm M, Madry K, Germing U, Almeida AM, Tatic A, Savic A, Simec NG, van Marrewijk C, Guerci-Bresler A, Sanhes L, Luno E, Culligan D, Beyne-Rauzy O, Burgstaller S, Blijlevens N, Bowen D, de Witte T. Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS. Leuk Res, 2018. 67: 21-6.

16. Constantinides C, Maguire M, McNeill E, Carnicer R, Swider E, Srinivas M, Carr CA, Schneider JE. Fast, quantitative, murine cardiac 19F MRI/MRS of PFCE-labeled progenitor stem cells and macrophages at 9.4T. PLoS One, 2018. 13(1): e0190558.

17. Schaper F, van Spriel AB. Antitumor Immunity Is Controlled by Tetraspanin Proteins. Front Immunol, 2018. 9: 1185.

18. Swider E, Staal AHJ, van Riessen NK, Jacobs L, White PB, Fokkink R, Janssen GJ, van Dinther E, Figdor CG, de Vries IJM, Koshkina O, Srinivas M. Design of triphasic poly(lactic-co-glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applications. Rsc Advances, 2018. 8(12): 6460-70.

19. Swider E, Daoudi K, Staal AHJ, Koshkina O, van Riessen NK, van Dinther E, de Vries IJM, de Korte CL, Srinivas M. Clinically-Applicable Perfluorocarbon-Loaded Nanoparticles For In vivo Photoacoustic, (19)F Magnetic Resonance And Fluorescent Imaging. Nanotheranostics, 2018. 2(3): 258-68.

20. Perkovic E, Textor J, Kalisch M, Maathuis MH. Complete graphical characterization and construction of adjustment sets in Markov equivalence classes of ancestral graphs. Journal of Machine Learning Research, 2018.